Predicting outcome in primary biliary cirrhosis



Título del documento: Predicting outcome in primary biliary cirrhosis
Revista: Annals of hepatology
Base de datos: PERIÓDICA
Número de sistema: 000412919
ISSN: 1665-2681
Autores: 1
2
1
Instituciones: 1Erasmus University, Medical Center, Rotterdam, Zuid Holland. Países Bajos
Año:
Periodo: Jul-Ago
Volumen: 13
Número: 4
Paginación: 316-326
País: México
Idioma: Inglés
Tipo de documento: Estadística o encuesta
Enfoque: Analítico
Resumen en inglés Primary biliary cirrhosis (PBC) is a slowly progressive autoimmune liver disease that may ultimately result in liver failure and premature death. Predicting outcome is of key importance in clinical management and an essential requirement for patients counselling and timing of diagnostic and therapeutic interventions. The following factors are associated with progressive disease and worse outcome: young age at diagnosis, male gender, histological presence of cirrhosis, accelerated marked ductopenia in relation to the amount of fibrosis, high serum bilirubin, low serum albumin levels, high serum alkaline phosphatase levels, esophageal varices, hepatocellular carcinoma (HCC) and lack of biochemical response to ursodeoxycholic acid (UDCA). The prognostic significance of symptoms at diagnosis is uncertain. UDCA therapy and liver transplantation have a significant beneficial effect on the outcome of the disease. The Mayo risk score in PBC can be used for estimating individual prognosis. The Newcastle Varices in PBC Score may be a useful clinical tool to predict the risk for development of esophageal varices. Male gender, cirrhosis and non-response to UDCA therapy in particular, are risk factors for development of HCC
Disciplinas: Medicina
Palabras clave: Diagnóstico,
Gastroenterología,
Oncología,
Factores pronósticos,
Modelos de predicción,
Trasplantes,
Hígado,
Várices esofágicas,
Carcinoma hepatocelular
Keyword: Medicine,
Diagnosis,
Gastroenterology,
Oncology,
Prognostic factors,
Prediction models,
Transplantation,
Liver,
Esophageal varices,
Hepatocellular carcinoma
Texto completo: Texto completo (Ver PDF)